Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of ArizonaGlobeNewsWire • 07/28/22
Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-MarketGlobeNewsWire • 04/28/22
Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc. (NASDAQ: SBFM)Accesswire • 04/28/22
Multiple Promising Treatments Accentuate the Bull Case for Sunshine BiopharmaInvestorPlace • 04/26/22
Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-MarketGlobeNewsWire • 04/26/22
Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer CellsGlobeNewsWire • 04/25/22
Sunshine Biopharma's Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer CellsGlobeNewsWire • 04/05/22
Aegis Capital Corp. acted as Exclusive Placement Agent on an $8 Million Private Placement for Sunshine Biopharma Inc. (NASDAQ: SBFM)Accesswire • 03/15/22
Sunshine Biopharma, Inc. Announces Closing of $8.0 Million Private Placement Priced At-the-MarketGlobeNewsWire • 03/14/22
Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-MarketGlobeNewsWire • 03/10/22